To verify whether inhibition of KIF11 could alleviate the development of breast cancer in vitro, the shRNA was used to downregulate the expression of KIF11 in estrogen receptor (ER)‐positive breast cancer cell line MCF‐7 and ER‐negative breast cancer cell line MDA‐MB‐231. This evidence concerns the gene ESR1 and breast carcinoma.